Global Health AGM voting results confirm dividend and director re-election

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Global Health Ltd approved all four resolutions at its 22nd AGM with near-unanimous shareholder support
  • Final dividend of ₹0.50 per equity share for FY26 was declared and approved
  • Group CEO Pankaj Sahni was re-elected as a director upon retirement by rotation
  • Audited standalone and consolidated financial statements for FY26 were adopted without qualifications
powered bylight_fuzz_icon
51100778

*this image is generated using AI for illustrative purposes only.

Global Health disclosed the voting results of its 22nd Annual General Meeting held on September 16, 2026. Shareholders approved all four ordinary resolutions with overwhelming support, including the declaration of a final dividend of ₹0.50 per equity share for FY26.

The meeting, conducted via video conferencing, also saw the re-election of Group CEO Pankaj Sahni as a director. The audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026, were adopted without any qualifications from the auditors.

Voting Results

The consolidated scrutinizer’s report, issued by M/s Mukesh Agarwal & Co., detailed the vote counts for each resolution. Remote e-voting was conducted from September 12, 2026, to September 15, 2026, while e-voting during the AGM remained open for 15 minutes after the conclusion of the meeting.

Resolution Votes in Favour (% of valid votes) Votes Against (% of valid votes) Status
Adoption of Financial Statements (FY26) 99.9999% 0.0001% Approved
Declaration of Final Dividend (₹0.50) 99.9997% 0.0003% Approved
Re-election of Pankaj Sahni 99.7679% 0.2321% Approved
Approval of Cost Auditors' Remuneration 99.9998% 0.0002% Approved

Key Resolutions Passed

Shareholders approved the following ordinary resolutions:

  • Adoption of audited standalone and consolidated financial statements for FY26.
  • Declaration of final dividend of ₹0.50 per equity share.
  • Re-election of Mr. Pankaj Sahni (DIN: 07132999) as a director upon retirement by rotation.
  • Approval of remuneration for M/s Ramanath Iyer & Co. as cost auditors for FY27.

Management Commentary

Dr. Naresh Trehan, Chairman & Managing Director, opened the meeting by thanking shareholders for their continued support. He highlighted the company’s commitment to excellence in healthcare delivery and patient care.

Mr. Pankaj Sahni, Group CEO & Director, updated members on the key financial and operational achievements for FY26. He acknowledged the guidance provided by the Board of Directors and the support from all stakeholders.

Meeting Details

The quorum was present at the start of the meeting. As on the cut-off date of September 10, 2026, there were 138,076 shareholders entitled to vote. M/s Mukesh Agarwal & Co., Company Secretaries, served as the scrutinizer for the voting process. The results were unblocked on September 16, 2026, in the presence of two independent witnesses.

Historical Stock Returns for Global Health

1 Day5 Days1 Month6 Months1 Year5 Years
-2.78%-2.86%-12.56%+13.90%-8.27%+198.58%

How does the ₹0.50 per share dividend compare to Global Health's payout ratios in previous fiscal years, and what does this signal about future capital allocation priorities?

With Pankaj Sahni re-elected as Group CEO, what specific strategic initiatives or operational targets has he outlined for FY27 to drive growth in the healthcare sector?

Given the near-unanimous shareholder approval, are there any emerging governance concerns or minority stakeholder dissent that might impact future board resolutions?

Global Health hosts investor meetings on September 17 and 18

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Global Health hosts group investor meetings on September 17 and 18, 2026
  • First session at Jefferies India Forum 2026 in Gurugram on September 17
  • Second session at Kotak Healthcare Forum 2026 in Mumbai on September 18
  • Meetings are in-person; no unpublished price-sensitive info to be shared
powered bylight_fuzz_icon
50672046

*this image is generated using AI for illustrative purposes only.

Global Health has scheduled group meetings with analysts and investors on September 17 and 18, 2026. The engagements are part of larger industry forums organized by Jefferies and Kotak.

Meeting details

The company’s management will participate in two separate group sessions across two consecutive days. These meetings serve as a platform for direct engagement with market participants. No unpublished price-sensitive information is proposed to be shared during these interactions.

Parameter Details
Meeting dates September 17 and 18, 2026
Participants Analysts and investors
Format Group meetings

Schedule specifics

The first session is scheduled for September 17, 2026, as part of the Jefferies India Forum 2026. This meeting will be held in person in Gurugram. The second session follows on September 18, 2026, under the Kotak Healthcare Forum 2026 banner, taking place in person in Mumbai.

Global Health Limited confirmed these details pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule remains subject to change in case of unforeseen circumstances.

Historical Stock Returns for Global Health

1 Day5 Days1 Month6 Months1 Year5 Years
-2.78%-2.86%-12.56%+13.90%-8.27%+198.58%

How might the insights shared at the Jefferies and Kotak forums influence Global Health's stock valuation in the immediate quarter following September 2026?

What specific strategic initiatives or pipeline updates is Global Health likely to highlight to differentiate itself from competitors during these healthcare sector forums?

Could the direct engagement with analysts signal an upcoming capital raising effort or M&A activity for Global Health in late 2026 or early 2027?

More News on Global Health

1 Year Returns:-8.27%